Weiss Functional Impairment Rating Scale-Parent Report Outcomes From a Dose-Optimization Study of AM and PM Once-Daily Dosing with Guanfacine Extended Release in Children with ADHD


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 1.3
Weiss Functional Impairment Rating Scale-Parent Report Outcomes From a Dose-Optimization Study of AM and PM Once-Daily Dosing with Guanfacine Extended Release in Children with ADHD

Wednesday, October 19, 2011

Margaret Weiss, M.D., FRCPC, Ph.D., Provincial ADHD Program, University of British Columbia, Vancouver, BC, Canada

Carla White, Shire Pharmaceuticals Inc., Basingstoke, United Kingdom

Gail Enright, M.E., Shire Development Inc., Wayne, PA

Vanja Sikirica, M.P.H., Pharm.D., Shire Pharmaceuticals Inc., Wayne, PA

Sharon Youcha, M.D., Shire Development Inc., Wayne, PA